Testing Until the Doctor Comes? Why Switzerland Is Moving Away from Rigid Three-Month Intervals in 2026 – and What That Means for Sex Workers
For years, a simple rule of thumb applied in the erotic industry: get tested every three months, check everything, have your certificate ready. Those who regularly tested felt they were on the safe side – and many businesses, agencies, and clients expected exactly that. In 2026, this certainty is being shaken. Not because sexually transmitted infections (STIs) have become rarer – quite the opposite, numbers are rising. But because experts have recognized that more testing doesn’t automatically mean more protection and in some cases can actually cause harm.
For people who work with sexuality professionally, this is no academic debate. It’s about time, money, antibiotics, your own body – and the question of what a test actually tells you. This article puts the current Swiss situation in context: the new numbers, the surprising reversal in testing intervals, the hotly debated Doxy-PEP, and what a smart prevention protocol in 2026 really looks like.
The Numbers: STIs Are on the Rise – but Not All Equally
The statistics are clear. In Switzerland, around 6,800 cases of gonorrhea were reported in 2024 – nearly twelve percent more than the previous year. Chlamydia remains by far the most frequently reported STI, with over 12,000 reported cases; its numbers have doubled within roughly ten years. Syphilis has also been rising steadily for years.
What’s interesting is the regional distribution. The STI Index of the Federal Office of Public Health (BAG) shows a clear urban-rural gradient: Zurich and Geneva lead the statistics. For syphilis, Zurich has an index value of around 24.9, followed by Geneva (22.1) and Basel-Stadt (17.5) – the national average is just under 8.8. For gonorrhea, the gap is even more pronounced. This is no coincidence: wherever more testing occurs and where urban scenes with high partner density exist, more infections are found. A high value doesn’t necessarily mean „more dangerous canton,“ but often simply „better detection.“
Critical to understanding the new recommendations is a distinction that has long been overlooked: not all of these infections are equally dangerous. HIV, syphilis, and hepatitis can cause severe, sometimes irreversible damage if left untreated. Chlamydia and gonorrhea, by contrast, often run asymptomatic and heal without problems when treated – severe complications are, contrary to what has long been communicated, comparatively rare. This exact differentiation is the key to the turnaround.
The Turnaround: Why „Test Everything Every Three Months“ Has Had Its Day
For years, the recommendation for people at elevated risk was to get tested regularly – often every three months – for chlamydia, gonorrhea, syphilis, and HIV, even without any symptoms. In 2026, this logic is increasingly being questioned. The reason is a rethink based on three observations.
First: antibiotic resistance. Every positive test for gonorrhea or chlamydia leads to antibiotic treatment. If you test every three months, you’ll statistically find something more often – and treat accordingly often, including asymptomatic infections that would never have caused problems. Intensive screening strategies today are considered drivers of resistance and additionally disrupt the body’s natural microbial balance. With gonorrhea, this is particularly serious: the pathogens are becoming increasingly resistant, which is why Switzerland today relies especially on ceftriaxone and uses azithromycin, the former standard drug, more cautiously. Every unnecessary treatment today shrinks the arsenal for tomorrow.
Second: limited benefit. Despite years of continuous screening, there has been no decline in chlamydia and gonorrhea. Many infections remain asymptomatic, sometimes disappear on their own – and the testing hasn’t slowed transmission. When effort shows no measurable effect, you have to be allowed to question it.
Third: false alarms and collateral damage. No test is perfect. A gonorrhea swab in someone without symptoms can produce a false positive – with real consequences: unnecessary antibiotics, uncertainty, in the worst case, mistrust in a relationship. Current Swiss expert recommendations (such as the medix guideline) therefore note that a gonorrhea test in asymptomatic people isn’t always worthwhile.
The result is not a call to stop testing. It’s a shift from „test everything regularly“ to „test the right things specifically“: symptom-oriented, risk-adjusted, with clear focus on infections that really do harm – HIV, syphilis, hepatitis C.
What Does This Mean Concretely for a Sensible Testing Interval?
Those working with many contacts still need structure – just a smarter one. A contemporary approach in 2026 rests on three pillars.
1. Take Symptoms Seriously – Immediately, Not at the End of the Quarter
Burning during urination, unusual discharge, itching, sores, skin changes in the genital, anal, or oral area, swollen lymph nodes, or unexplained rash: these are reasons for an immediate, targeted test – regardless of when the last routine check was. Symptom-oriented testing captures precisely those cases where treatment really matters.
2. Concentrate Baseline Screening on What Matters
For preventive screening without symptoms, focusing on infections with serious progression is recommended: HIV, syphilis, hepatitis C – and depending on the situation, chlamydia and gonorrhea. How often depends on actual risk: number and turnover of partners, condom use, practices. For many, a rhythm of six to twelve months is more appropriate than a rigid three-month interval – for individuals with very many unprotected contacts, more frequent testing may remain sensible. This assessment belongs in a confidential counseling conversation, not in a blanket business rule.
3. Understand the Window Period – Otherwise the Test Lies
A test is always only a snapshot of the past. Between infection and detectability lies the window period. With HIV, a laboratory test is reliable only about 15 days after a risk situation at the earliest; an infection can only be safely ruled out after roughly six weeks; an HIV self-test even needs twelve weeks. Other STIs also cannot be reliably detected for several weeks after the risk contact. This has an uncomfortable consequence: A „clean“ test result today says nothing about yesterday’s contact. This is precisely why the certificate as a safety promise to clients is deceptive – more on that shortly.
Doxy-PEP: The Big Debate of 2026 – and Its Limits
Hardly any topic is being discussed as intensively right now as Doxy-PEP: taking the antibiotic doxycycline after unprotected sex to prevent bacterial STIs. In March 2026, the Federal Commission on Questions Regarding Sexually Transmitted Infections (EKSI) published an official recommendation on this, and in May 2026, the WHO followed with its first global recommendation.
The key points of the Swiss recommendation: a single dose of 200 mg doxycycline within 24 to at most 72 hours after sexual intercourse, no more than 200 mg per 24 hours. The greatest benefit is in preventing syphilis (and partly chlamydia); against gonorrhea, it’s barely reliable due to resistance.
But it’s critical for whom Doxy-PEP is intended – and here it becomes differentiated for the erotic industry. The EKSI recommends it explicitly only for people at high risk and primarily for men who have sex with men, as well as trans women with male partners, who practice unprotected sex with changing partners and have already had a bacterial STI. For cisgender women, the data is significantly weaker – studies so far haven’t shown convincing protection here. Doxy-PEP is therefore not a blanket prevention tool for all sex workers and replaces neither condoms nor vaccination nor testing.
The Commission is intentionally cautious, and for good reason: broad, uncontrolled use of antibiotics for prevention is exactly the dynamic that fuels resistance. Those considering Doxy-PEP should do so with medical guidance – as part of an overall concept of vaccination, testing, and partner notification, not as self-medication from the internet.
The Underestimated Gold Standard: Vaccination
In all the testing and antibiotic debate, one point often gets lost that is simply the most effective: vaccinations. Against HPV (human papillomavirus, which causes genital warts and several types of cancer) and against hepatitis A and B, safe, effective vaccines exist. They provide lasting protection, cause no resistance, and make part of the screening question simply unnecessary. For people with many sexual contacts, they may be the single most cost-effective prevention investment – a conversation with your GP or a checkpoint clarifies your vaccination status.
The Certificate Dilemma: What a Test Promises – and What It Doesn’t
Here lies the real crux for the industry. The medical profession is moving toward „targeted, less frequent, smarter“ – while in many parts of the scene, the cult of the current certificate persists. A business demands a test from last week, a client feels safer with a piece of paper, a colleague advertises „regularly tested.“
But as shown above, a certificate is a snapshot with a window period. It can create a false sense of security and paradoxically devalue the condom – on the logic of „you’re tested anyway.“ This exact logic increases risk rather than reducing it. Realistic handling in 2026 therefore means: The condom remains the backbone of prevention, because it protects at the moment of contact, independent of window periods and papers. Tests, vaccinations, and possibly Doxy-PEP are supplements – not replacements.
When talking to clients about safety, you can represent this message confidently: protection doesn’t come from a piece of paper, but from consistent behavior. That’s not a weakness in your offering – it’s professional clarity.
Where You Can Get Tested Confidentially in Switzerland and Get Advice
A central, often underestimated fact: In Switzerland, there is no compulsory testing for sex workers. Testing is voluntary, and that’s a deliberate public health choice – compulsion drives people away from care, trust brings them in. Everyone has the right to access health services and to support that enables safe work.
Contact points operate anonymously, inexpensively or free of charge, and confidentially:
- Checkpoints and specialist services in larger cities offer low-threshold HIV/STI testing and counseling.
- Sexual Health Switzerland and Aids Hilfe Switzerland provide information on testing sites and deliver current, understandable recommendations.
- Specialized services for sex workers – such as Isla Victoria in Zurich or MariaMagdalena in eastern Switzerland – combine testing with counseling on rights, health, and working conditions, sometimes with anonymous infectious disease consultations.
The advantage of such specialized services: nobody there judges your work. Counseling is tailored to your real-life situation – including the question of which testing interval actually fits your individual case.## Conclusion: Less Ritual, More Strategy
STI prevention in Switzerland is coming of age in 2026. The reflexive three-month routine is giving way to a differentiated approach: consistently monitoring serious infections, responding symptomatically and quickly, avoiding over-screening for less serious infections, vaccinating consistently – and using antibiotics, including doxy-PEP, judiciously and under medical supervision.
For people working in the sex industry, this represents a chance to break free from certificate requirements: the thickest test booklet doesn’t provide the best protection, but rather a well-thought-out, individually tailored protocol does. Those who understand the connections make better decisions for their own bodies – and approach clients and employers with genuine expertise. In the end, that’s the most effective prevention of all: informed self-determination.
This article is not a substitute for medical advice. For individual recommendations regarding test intervals, vaccinations, and doxy-PEP, consult a sexual health clinic or your doctor.